Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
text
Tags
arch venture partners
artificial intelligence
bill martin
bio
biotech
drug development
executive
funding
gv
health
johnson & johnson
julie sunderland
machine learning
managing partner
neuroscience
polaris partners
science
startups
What
drugs
3
×
medicine
3
×
treatments
3
×
million
patients
using
access
agency
analysed
approach
benefits
betting
big
blackthorn
body
brexit
britain
broken
challenges
company
country
create
currently
design
designed
disorders
dlc
effective
ema
european
evil
exaggerate
favour
finding
flawed
great
gv
health
hopelessly
isn't
Language
Current search:
treatments
×
medicine
×
drugs
×
@techcrunch.com
4 years ago
Neurobehavioral health company Blackthorn pulls in $76 million from GV to treat mental disorders
@theverge.com
7 years ago
UK patients could wait a year longer for new drugs after Brexit
@eurogamer.net
7 years ago
Even with the Marketing and Malpractice DLC, Big Pharma just isn't evil enough
